News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
21,792 Results
Type
Article (1842)
Company Profile (7)
Press Release (19943)
Multimedia
Podcasts (1)
Webinars (2)
Section
Business (6838)
Career Advice (63)
Deals (858)
Drug Delivery (2)
Drug Development (2516)
Employer Resources (9)
FDA (285)
Job Trends (483)
News (10405)
Policy (764)
Tag
2024 BioCapital Digital (2)
2024 Biotech Bay Standard (1)
2024 Genetown Standard (1)
2026 BioCapital Elite (1)
Academia (266)
Alliances (1457)
ALS (5)
Alzheimer's disease (54)
Antibody-drug conjugate (ADC) (7)
Approvals (282)
Artificial intelligence (2)
Autoimmune disease (1)
Bankruptcy (6)
Best Places to Work (380)
BIOSECURE Act (2)
Biosimilars (2)
Biotechnology (5)
Bladder cancer (2)
Breast cancer (3)
Cancer (64)
Cardiovascular disease (3)
Career advice (59)
Career pathing (1)
CAR-T (4)
Cell therapy (12)
Clinical research (1942)
Collaboration (15)
Compensation (9)
Complete response letters (1)
COVID-19 (116)
CRISPR (2)
C-suite (10)
Cystic fibrosis (2)
Data (44)
Depression (1)
Diabetes (4)
Diagnostics (113)
Digital health (1)
Diversity, equity & inclusion (4)
Drug discovery (2)
Drug pricing (2)
Duchenne muscular dystrophy (2)
Earnings (1728)
Editorial (6)
Employer branding (2)
Employer resources (8)
Events (3575)
Executive appointments (32)
FDA (304)
Featured Employer (2)
Funding (43)
Gene editing (7)
Gene therapy (12)
GLP-1 (22)
Government (142)
Guidances (3)
Healthcare (849)
Huntington's disease (2)
Immunology and inflammation (5)
Infectious disease (118)
Intellectual property (2)
Interviews (7)
IPO (424)
IRA (2)
Job creations (107)
Job search strategy (51)
Layoffs (20)
Leadership (2)
Legal (147)
Liver cancer (1)
Lung cancer (13)
Lymphoma (13)
Management (1)
Manufacturing (6)
Medical device (173)
Medtech (174)
Mergers & acquisitions (460)
Metabolic disorders (11)
Multiple sclerosis (7)
Neurodegenerative disease (3)
Neuropsychiatric disorders (1)
Neuroscience (77)
NextGen: Class of 2025 (340)
Non-profit (392)
Northern California (49)
Now hiring (1)
Obesity (5)
Opinion (10)
Ovarian cancer (2)
Pain (1)
Pancreatic cancer (4)
Parkinson's disease (8)
Partnered (1)
Patents (2)
Patient recruitment (2)
People (3057)
Phase I (646)
Phase II (936)
Phase III (590)
Pipeline (29)
Policy (8)
Postmarket research (44)
Preclinical (295)
Press Release (2)
Prostate cancer (2)
Radiopharmaceuticals (5)
Rare diseases (9)
Real estate (228)
Recruiting (5)
Regulatory (523)
Research institute (179)
Resumes & cover letters (9)
Schizophrenia (1)
Series A (9)
Series B (5)
Sickle cell disease (1)
Southern California (34)
Special edition (1)
Spinal muscular atrophy (13)
Startups (224)
Tariffs (2)
The Weekly (1)
United States (619)
Vaccines (22)
Venture capitalists (4)
Weight loss (7)
Women's health (1)
Date
Today (8)
Last 7 days (19)
Last 30 days (68)
Last 365 days (868)
2025 (250)
2024 (1004)
2023 (1273)
2022 (1859)
2021 (2416)
2020 (1704)
2019 (1814)
2018 (1457)
2017 (914)
2016 (990)
2015 (1100)
2014 (864)
2013 (768)
2012 (822)
2011 (841)
2010 (755)
Location
Africa (31)
Alabama (2)
Arizona (4)
Asia (1055)
Australia (83)
California (92)
Canada (43)
China (17)
Colorado (6)
Connecticut (3)
Delaware (3)
Europe (1566)
Florida (13)
Georgia (1)
Idaho (1)
Illinois (31)
India (1)
Indiana (6)
Japan (3)
Kansas (2)
Maryland (191)
Massachusetts (99)
Michigan (10)
Minnesota (2)
Missouri (1)
New Hampshire (2)
New Jersey (67)
New Mexico (1)
New York (54)
North Carolina (15)
Northern California (49)
Ohio (3)
Pennsylvania (35)
South America (31)
South Carolina (1)
Southern California (34)
Tennessee (2)
Texas (6)
Virginia (4)
Washington D.C. (2)
Washington State (7)
Wisconsin (1)
21,792 Results for "scholar rock".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Neurodegenerative disease
Scholar Rock’s Shares Soar 300% After Phase III Win in Spinal Muscular Atrophy
With Monday’s data from SAPPHIRE, Scholar Rock is building toward regulatory submissions for apitegromab in spinal muscular atrophy in the first quarter of 2025.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Scholar Rock to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
2 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 18, 2025
April 21, 2025
·
3 min read
Press Releases
Scholar Rock Appoints David L. Hallal as Chief Executive Officer; Also Announces Addition of Three Key Leaders to Scale for Next Phase of Growth
April 28, 2025
·
9 min read
Press Releases
Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress
February 27, 2025
·
18 min read
Press Releases
Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference
March 17, 2025
·
13 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 14, 2025
March 17, 2025
·
3 min read
Genetown
Scholar Rock to Participate in Upcoming Investor Conferences - May 20, 2024
Scholar Rock today announced that management will participate in the following upcoming investor conferences in June.
May 20, 2024
·
3 min read
Genetown
Scholar Rock to Host Investor Day on May 22, 2024
Scholar Rock today announced it will host an Investor Day on Wednesday, May 22, 2024 beginning at 8:30 a.m. ET in New York City.
May 14, 2024
·
3 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 14, 2025
February 17, 2025
·
3 min read
1 of 2,180
Next
